The Enterprise Value as of July 2024 (TTM) for Ventyx Biosciences, Inc. (VTYX) is 77.57M

According to Ventyx Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 77.57M. This represents a change of -92.60% compared to the average of 1.05B of the last 4 quarters.

Ventyx Biosciences, Inc. (VTYX) Historical Enterprise Value (quarterly & annually)

How has VTYX Enterprise Value performed in the past?

The mean historical Enterprise Value of Ventyx Biosciences, Inc. over the last ten years is 964.70M. The current 77.57M Enterprise Value has changed 704.07% with respect to the historical average. Over the past ten years (40 quarters), VTYX's Enterprise Value was at its highest in in the September 2023 quarter at 2.00B. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.

Ventyx Biosciences, Inc. (VTYX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ventyx Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ventyx Biosciences, Inc. (VTYX) Average Enterprise Value

How has VTYX Enterprise Value performed in the past?

The current Enterprise Value of Ventyx Biosciences, Inc. (VTYX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Ventyx Biosciences, Inc. (VTYX) Enterprise Value vs. Peers

How is VTYX’s Enterprise Value compared to its peers?

Ventyx Biosciences, Inc.’s Enterprise Value is less than Arcellx, Inc. (3.38B), less than Immunocore Holdings plc (1.20B), less than Vaxcyte, Inc. (8.56B), less than DICE Therapeutics, Inc. (2.21B), less than Nuvalent, Inc. (5.17B), less than Cerevel Therapeutics Holdings, Inc. (8.18B), less than Travere Therapeutics, Inc. (1.11B), less than Structure Therapeutics Inc. (2.11B), less than Replimune Group, Inc. (0), less than Ascendis Pharma A/S (708.54M), less than United Therapeutics Corporation (7.32B), less than IDEAYA Biosciences, Inc. (14.35B), less than Protagonist Therapeutics, Inc. (3.46B), less than Verona Pharma plc (2.19B), less than Syndax Pharmaceuticals, Inc. (1.58B), less than null (1.97B),

Build a custom stock screener for Ventyx Biosciences, Inc. (VTYX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ventyx Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ventyx Biosciences, Inc. (VTYX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ventyx Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.